Dasabuvir
| CAS No. | 1132935-63-7 | Cat. No. | BCP09324 |
| Name | Dasabuvir | ||
| Synonyms | ABT-333;ABT 333;ABT333; | ||
| Formula | C26H27N3O5S | M. Wt | 493.57 |
| Description | Dasabuvir, also known as ABT-333, is a non-nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C. In the United States, it is approved by the Food and Drug Administration for use in combination with ombitasvir, paritaprevir, and ritonavir in the product Viekira Pak. Dasabuvir acts as a NS5B (an RNA-directed RNA polymerase) inhibitor. | ||
| Pathways | Microbiology/Virology | ||
| Targets | HCV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.